Pyxis Oncology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	5.77	15.42	19.47	9.66	179.29	274.74
Short-Term Investments	35.25	51.44	107.46	109.63	-	-
Cash & Short-Term Investments	41.02	66.86	126.93	119.3	179.29	274.74
Cash Growth	-61.09%	-47.33%	6.40%	-33.46%	-34.74%	3300.19%
Other Current Assets	4.55	5.25	5.51	5.31	7.32	3.94
Total Current Assets	45.57	72.11	132.44	124.6	186.61	278.67
Net Property, Plant & Equipment	18.73	19.42	22.14	24.81	24.77	1.24
Other Intangible Assets	-	-	2.6	24.31	-	-
Other Long-Term Assets	-	-	-	-	-	0.11
Total Assets	64.3	91.52	157.18	173.73	211.38	280.02
Accounts Payable	4.99	10.89	4.86	3.9	7.1	11.95
Accrued Expenses	9.79	8.55	11.37	12.97	24.54	6.59
Current Portion of Leases	1.76	1.69	1.45	1.23	-	0.17
Unearned Revenue	-	-	-	7.66	-	-
Total Current Liabilities	16.53	21.13	17.68	25.76	31.63	18.71
Long-Term Leases	16.5	16.98	18.75	20.1	18.92	-
Other Long-Term Liabilities	-	-	-	2.16	-	-
Total Long-Term Liabilities	16.5	16.98	18.75	22.26	18.92	-
Total Liabilities	33.03	38.11	36.43	48.02	50.56	18.71
Common Stock	0.06	0.06	0.06	0.05	0.03	0.03
Additional Paid-in Capital	497.65	496.47	484.08	411.82	373.23	353
Accumulated Other Comprehensive Income	-	0.05	0.17	0.06	-	-
Retained Earnings	-466.45	-443.18	-363.56	-286.23	-212.44	-91.72
Total Common Shareholders' Equity	31.27	53.41	120.75	125.7	160.82	261.31
Shareholders' Equity	31.27	53.41	120.75	125.7	160.82	261.31
Total Liabilities & Equity	64.3	91.52	157.18	173.73	211.38	280.02
Total Debt	18.26	18.67	20.2	21.33	18.92	0.17
Net Cash (Debt)	22.76	48.18	106.73	97.97	160.37	274.57
Net Cash Growth	-52.76%	-54.85%	8.95%	-38.91%	-41.59%	3661.23%
Net Cash Per Share	0.36	0.78	1.83	2.46	4.86	32.33
Book Value	31.27	53.41	120.75	125.7	160.82	261.31
Book Value Per Share	0.50	0.86	2.07	3.15	4.87	30.77
Tangible Book Value	31.27	53.41	118.15	101.4	160.82	261.31
Tangible Book Value Per Share	0.50	0.86	2.02	2.54	4.87	30.77

SEC Filings: 10-K · 10-Q